Other
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Thermo Fisher Scientific Cash Provided by (Used in) Investing Activity, Including Discontinued Operation decreased by 1600.4% to -$8.96B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1600.4%, from -$527.00M to -$8.96B.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2017
Last reportedQ1 2026May 1, 2026
How to read this metric
Reflects the overall net movement of cash into or out of the investment portfolio and capital assets.
Detailed definition
The total net cash flow from investing activities, aggregating both continuing and discontinued operations. It provides...
Peer comparison
Standard consolidated cash flow metric across all industries.
Metric ID:
other_net_cash_provided_by_used_in_investing_activitiesHistorical Data
13 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$626.00M | -$616.00M | -$670.00M | -$419.00M | -$545.00M | -$3.14B | -$443.00M | -$1.18B | -$2.03B | -$253.00M | -$3.58B | -$527.00M | -$8.96B |
| QoQ Change | — | +1.6% | -8.8% | +37.5% | -30.1% | -476.5% | +85.9% | -166.6% | -71.9% | +87.5% | <-999% | +85.3% | <-999% |
| YoY Change | — | — | — | +33.1% | +11.5% | -369.0% | -5.7% | -116.7% | +35.4% | +42.9% | -203.0% | +74.0% | <-999% |
Range-$8.96B – -$253.00M
CAGR+142.8%
Avg YoY Growth-209.8%
Median YoY Growth+2.9%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's cash provided by (used in) investing activity, including discontinued operation?
- Thermo Fisher Scientific (TMO) reported cash provided by (used in) investing activity, including discontinued operation of -$8.96B in Q1 2026.
- How has Thermo Fisher Scientific's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
- Thermo Fisher Scientific's cash provided by (used in) investing activity, including discontinued operation decreased by 1600.4% year-over-year, from -$527.00M to -$8.96B.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow from all investing activities, including both ongoing and discontinued operations.